Our blog, More@MedLetter, consists of short blog posts that contain comments on topics in The Medical Letter or are of special interest to the medical community. The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of previously approved drugs in its newsletter, The Medical Letter on Drugs and Therapeutics. Our publication is intended specifically to meet the needs of busy healthcare professionals who want unbiased, reliable and timely drug information. This commitment to unbiased drug information ensures that subscribers can rely on our content to make the best decisions for their patients without the influence of the pharmaceutical companies or any other commercial entity.
Staff
Mark Abramowicz, M.D., President
Jean-Marie Pflomm, Pharm.D, Vice President, Editor in Chief